Serial Number | 79393448 |
Word Mark | AVIDICURE |
Filing Date | Friday, January 26, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Thursday, December 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Educational services, namely, arranging and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, or drug and pharmaceutical development; training services, namely, providing training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, or drug and pharmaceutical development. |
Goods and Services | Pharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases, or infectious diseases; biopharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases, or infectious diseases. |
Goods and Services | Chemical products for use in industry, science, and photography, namely, monoclonal antibodies and recombinant proteins used in scientific in-silico, in-vitro, in-vivo, or clinical research and development relating to immuno-oncology. |
Goods and Services | Legal services relating to the exploitation of patents; management and licensing of patents; licensing of intellectual property |
Goods and Services | Medical services; medical and pharmaceutical advisory and consultancy services; medical care services |
Goods and Services | Medical and scientific research services; industrial research services in the field of treatment for cancer, inflammatory diseases, auto immune diseases or infectious diseases; pharmaceutical and biopharmaceutical research and development services; development, research, laboratory analysis and testing of pharmaceutical and biopharmaceutical drugs and semi-finished chemicals and chemical products for use in pharmaceuticals; development of test systems in the nature of cell culture models, animal models and companion diagnostics for pharmaceutical and biopharmaceutical products; chemical analysis; computer system analysis and programming, namely, the development of prototypes and collection and processing of medical data for scientific research, development of databases in the medical, pharmaceutical and biopharmaceutical fields. |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 12, 2024 |
Primary Code | 045 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Avidicure B.V. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | NL |
Event Date | Event Description |
Thursday, April 11, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, April 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, April 18, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, August 21, 2024 | ASSIGNED TO EXAMINER |
Thursday, August 22, 2024 | NON-FINAL ACTION WRITTEN |
Friday, August 23, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, August 27, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, August 28, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Saturday, September 14, 2024 | REFUSAL PROCESSED BY IB |
Thursday, December 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 19, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |